Company / SG&A Expense
Perrigo SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$435.9M
FY2025
5-year range
$435.9M / $522.3M
FY2021-FY2025
Trend
-6.9%
vs FY2024
Sector context
#42 of 213
Health Care
What the data says
Perrigo's sg&a expense of $436M is higher than 80% of companies in the Health Care sector (FY2025). SG&A Expense has fluctuated over the past 10 years, ranging from $436M in FY2025 to $522M in FY2023.
Based on SEC 10-K filings.
$436M in FY2025 with a 5-year CAGR of -1.8%. Top quartile in the Health Care sector.
Improved from $522M to $436M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -3.1%
- 5-Year CAGR
- -1.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 213This company $435.9M Sector average $722.3M
▼
-39.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -1.8%, indicating a declining trend.
- In FY2025, sg&a expense decreased 6.9% year-over-year.
- Ranks #42 out of 213 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $435.9M | -6.9% |
| FY2024 | $468.0M | -10.4% |
| FY2023 | $522.3M | +9.2% |
| FY2022 | $478.5M | +0.4% |
| FY2021 | $476.5M | -0.4% |
| FY2020 | $478.5M | +3.8% |
| FY2019 | $461.1M | +2.0% |
| FY2018 | $452.2M | -1.9% |
| FY2017 | $461.1M | +2.0% |
| FY2016 | $452.2M | +17.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026